Fatty Liver Risk Assessment (MASLD / NAFLD)
Evaluate hepatic steatosis risk and liver fibrosis stage using metabolic markers and the FIB-4 Clinical Index.
Associated Metabolic Drivers:
High
Risk Tier
Elevated Risk of Hepatic Steatosis
Multiple metabolic risk factors (elevated BMI, waist circumference, and dyslipidemia) are present. Consider an abdominal ultrasound and liver enzyme screening (ALT/AST).
